MXPA06009723A - A mild body wash - Google Patents
A mild body washInfo
- Publication number
- MXPA06009723A MXPA06009723A MXPA/A/2006/009723A MXPA06009723A MXPA06009723A MX PA06009723 A MXPA06009723 A MX PA06009723A MX PA06009723 A MXPA06009723 A MX PA06009723A MX PA06009723 A MXPA06009723 A MX PA06009723A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- further characterized
- liquid
- soap
- surfactant
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims abstract description 322
- 239000004094 surface-active agent Substances 0.000 claims abstract description 79
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 20
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 19
- 239000003792 electrolyte Substances 0.000 claims abstract description 16
- 239000012071 phase Substances 0.000 claims description 120
- 239000000344 soap Substances 0.000 claims description 112
- 239000007788 liquid Substances 0.000 claims description 109
- 239000002245 particle Substances 0.000 claims description 81
- -1 alkyl ether sulphates Chemical class 0.000 claims description 63
- 210000003491 Skin Anatomy 0.000 claims description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- 229910001868 water Inorganic materials 0.000 claims description 45
- 230000002209 hydrophobic Effects 0.000 claims description 44
- 239000000463 material Substances 0.000 claims description 34
- 239000003795 chemical substances by application Substances 0.000 claims description 30
- 238000004140 cleaning Methods 0.000 claims description 29
- 238000005187 foaming Methods 0.000 claims description 26
- 239000008346 aqueous phase Substances 0.000 claims description 23
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 16
- 229920001296 polysiloxane Polymers 0.000 claims description 15
- 239000011780 sodium chloride Substances 0.000 claims description 13
- 235000002639 sodium chloride Nutrition 0.000 claims description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 11
- 239000000194 fatty acid Substances 0.000 claims description 11
- 239000002280 amphoteric surfactant Substances 0.000 claims description 9
- 239000002888 zwitterionic surfactant Substances 0.000 claims description 9
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 claims description 6
- 229940098760 STEARETH-2 Drugs 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 6
- 150000002430 hydrocarbons Chemical class 0.000 claims description 6
- 229940029983 VITAMINS Drugs 0.000 claims description 5
- 229940021016 Vitamin IV solution additives Drugs 0.000 claims description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 5
- 235000011152 sodium sulphate Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 229930003231 vitamins Natural products 0.000 claims description 5
- 239000000341 volatile oil Substances 0.000 claims description 5
- 150000003973 alkyl amines Chemical class 0.000 claims description 4
- 230000003255 anti-acne Effects 0.000 claims description 4
- 230000000111 anti-oxidant Effects 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 239000002738 chelating agent Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 239000011814 protection agent Substances 0.000 claims description 4
- 230000037072 sun protection Effects 0.000 claims description 4
- AZLWQVJVINEILY-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCOCCOCCO AZLWQVJVINEILY-UHFFFAOYSA-N 0.000 claims description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N Ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 3
- 229940100491 LAURETH-2 Drugs 0.000 claims description 3
- 235000019270 ammonium chloride Nutrition 0.000 claims description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 3
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003925 fat Substances 0.000 claims description 3
- QDHHCQZDFGDHMP-UHFFFAOYSA-N monochloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 claims description 3
- FUWVMBCPMRAWPG-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OCC(O)CO FUWVMBCPMRAWPG-UHFFFAOYSA-N 0.000 claims description 2
- PWVUXRBUUYZMKM-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCO PWVUXRBUUYZMKM-UHFFFAOYSA-N 0.000 claims description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-hydroxypropyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 claims description 2
- 229940045714 Alkyl sulfonate alkylating agents Drugs 0.000 claims description 2
- 229940096501 Sodium Cocoamphoacetate Drugs 0.000 claims description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 2
- 150000008052 alkyl sulfonates Chemical class 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N rac-1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- 239000001587 sorbitan monostearate Substances 0.000 claims description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 claims description 2
- 229940035048 sorbitan monostearate Drugs 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims 2
- 239000010410 layer Substances 0.000 description 34
- 239000000047 product Substances 0.000 description 31
- 238000002156 mixing Methods 0.000 description 30
- 239000000049 pigment Substances 0.000 description 29
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 25
- 229920000642 polymer Polymers 0.000 description 21
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 20
- 239000004166 Lanolin Substances 0.000 description 20
- 229940039717 Lanolin Drugs 0.000 description 20
- 235000019388 lanolin Nutrition 0.000 description 20
- 239000004615 ingredient Substances 0.000 description 16
- 239000004005 microsphere Substances 0.000 description 15
- 229960003237 betaine Drugs 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 125000004432 carbon atoms Chemical group C* 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 11
- 230000003750 conditioning Effects 0.000 description 11
- 230000000670 limiting Effects 0.000 description 11
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 11
- 239000010409 thin film Substances 0.000 description 11
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 11
- 238000005199 ultracentrifugation Methods 0.000 description 11
- 230000035882 stress Effects 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 125000000217 alkyl group Chemical group 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 239000004698 Polyethylene (PE) Substances 0.000 description 8
- 229960004106 citric acid Drugs 0.000 description 8
- 229920000573 polyethylene Polymers 0.000 description 8
- WSDISUOETYTPRL-UHFFFAOYSA-N DMDM hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 7
- 238000005520 cutting process Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 239000001993 wax Substances 0.000 description 7
- 210000001772 Blood Platelets Anatomy 0.000 description 6
- 239000004264 Petrolatum Substances 0.000 description 6
- 229940066842 Petrolatum Drugs 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 235000019271 petrolatum Nutrition 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- HFQBFCSVHWJVNK-UHFFFAOYSA-N sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate Chemical compound [Na+].CCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O HFQBFCSVHWJVNK-UHFFFAOYSA-N 0.000 description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 229960003504 Silicones Drugs 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N ethanolamine Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 5
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 229910010272 inorganic material Inorganic materials 0.000 description 5
- 239000011147 inorganic material Substances 0.000 description 5
- 239000010445 mica Substances 0.000 description 5
- 229910052618 mica group Inorganic materials 0.000 description 5
- 239000002480 mineral oil Substances 0.000 description 5
- 235000010446 mineral oil Nutrition 0.000 description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 125000000129 anionic group Chemical group 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 239000011247 coating layer Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 235000012343 cottonseed oil Nutrition 0.000 description 4
- 239000002385 cottonseed oil Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 239000012456 homogeneous solution Substances 0.000 description 4
- 239000002932 luster Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000011236 particulate material Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 235000012424 soybean oil Nutrition 0.000 description 4
- 239000003549 soybean oil Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000010215 titanium dioxide Nutrition 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- BVDRUCCQKHGCRX-UHFFFAOYSA-N 2,3-dihydroxypropyl formate Chemical compound OCC(O)COC=O BVDRUCCQKHGCRX-UHFFFAOYSA-N 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N AI2O3 Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- 229940107161 Cholesterol Drugs 0.000 description 3
- QDOXWKRWXJOMAK-UHFFFAOYSA-N Chromium(III) oxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 3
- 210000004080 Milk Anatomy 0.000 description 3
- 229920001451 Polypropylene glycol Polymers 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 229940102541 SODIUM TRIDECETH SULFATE Drugs 0.000 description 3
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M Sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 3
- XOLBLPGZBRYERU-UHFFFAOYSA-N Tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L disodium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate Chemical group CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- 239000004200 microcrystalline wax Substances 0.000 description 3
- 235000019808 microcrystalline wax Nutrition 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 125000004433 nitrogen atoms Chemical group N* 0.000 description 3
- 239000011368 organic material Substances 0.000 description 3
- NJRWNWYFPOFDFN-UHFFFAOYSA-L phosphonate(2-) Chemical compound [O-][P]([O-])=O NJRWNWYFPOFDFN-UHFFFAOYSA-L 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 230000002335 preservative Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- KLYDBHUQNXKACI-UHFFFAOYSA-M sodium;2-[2-(2-tridecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O KLYDBHUQNXKACI-UHFFFAOYSA-M 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- 229920001169 thermoplastic Polymers 0.000 description 3
- 239000004416 thermosoftening plastic Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 230000000699 topical Effects 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Chemical class 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- LGXVIGDEPROXKC-UHFFFAOYSA-N 1,1-Dichloroethene Chemical compound ClC(Cl)=C LGXVIGDEPROXKC-UHFFFAOYSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- 229940048299 ACETYLATED LANOLIN ALCOHOLS Drugs 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 235000019489 Almond oil Nutrition 0.000 description 2
- WUKWITHWXAAZEY-UHFFFAOYSA-L Calcium fluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 240000007170 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N Eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N Isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- 229940099367 LANOLIN ALCOHOLS Drugs 0.000 description 2
- 229940067606 Lecithin Drugs 0.000 description 2
- 235000019738 Limestone Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-UHFFFAOYSA-N Linoleic acid Chemical compound CCCCCC=CCC=CCCCCCCCC(O)=O OYHQOLUKZRVURQ-UHFFFAOYSA-N 0.000 description 2
- 229940078812 MYRISTYL MYRISTATE Drugs 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 229940067631 Phospholipids Drugs 0.000 description 2
- 229920001083 Polybutene Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N Resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940079862 Sodium Lauryl Sarcosinate Drugs 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N Triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- 235000019498 Walnut oil Nutrition 0.000 description 2
- 239000004164 Wax ester Substances 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 125000005376 alkyl siloxane group Chemical group 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- 235000013869 carnauba wax Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 239000003026 cod liver oil Substances 0.000 description 2
- 235000012716 cod liver oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910052593 corundum Inorganic materials 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229940075495 isopropyl palmitate Drugs 0.000 description 2
- 229940094522 laponite Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000006028 limestone Substances 0.000 description 2
- 229940049918 linoleate Drugs 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 125000004437 phosphorous atoms Chemical group 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine zwitterion Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 229920002050 silicone resin Polymers 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atoms Chemical group 0.000 description 2
- 235000020238 sunflower seed Nutrition 0.000 description 2
- 210000001519 tissues Anatomy 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000008170 walnut oil Substances 0.000 description 2
- 235000019386 wax ester Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- GYDYJUYZBRGMCC-INIZCTEOSA-N (2S)-2-amino-6-(dodecanoylamino)hexanoic acid Chemical compound CCCCCCCCCCCC(=O)NCCCC[C@H](N)C(O)=O GYDYJUYZBRGMCC-INIZCTEOSA-N 0.000 description 1
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 229940058012 1,3-dimethylol-5,5-dimethylhydantoin Drugs 0.000 description 1
- IQXJCCZJOIKIAD-UHFFFAOYSA-N 1-(2-methoxyethoxy)hexadecane Chemical compound CCCCCCCCCCCCCCCCOCCOC IQXJCCZJOIKIAD-UHFFFAOYSA-N 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- IEKHISJGRIEHRE-UHFFFAOYSA-N 16-methylheptadecanoic acid;propan-2-ol;titanium Chemical compound [Ti].CC(C)O.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O IEKHISJGRIEHRE-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical class CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-Methyl-2,4-pentanediol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 1
- AKWFJQNBHYVIPY-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO AKWFJQNBHYVIPY-UHFFFAOYSA-N 0.000 description 1
- ZQBJRVYLUFBBEQ-UHFFFAOYSA-N 2-[diamino(3-formamidopropyl)azaniumyl]acetate Chemical compound [O-]C(=O)C[N+](N)(N)CCCNC=O ZQBJRVYLUFBBEQ-UHFFFAOYSA-N 0.000 description 1
- AMRBZKOCOOPYNY-QXMHVHEDSA-N 2-[dimethyl-[(Z)-octadec-9-enyl]azaniumyl]acetate Chemical compound CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)CC([O-])=O AMRBZKOCOOPYNY-QXMHVHEDSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-hydroxystearic acid Chemical compound CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- DQAKJEWZWDQURW-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1=O DQAKJEWZWDQURW-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- IBYCEACZVUOBIV-UHFFFAOYSA-N 4-methylpentyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCC(C)C IBYCEACZVUOBIV-UHFFFAOYSA-N 0.000 description 1
- AUGIYYGVQDZOLU-UHFFFAOYSA-N 4-methylpentyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCC(C)C AUGIYYGVQDZOLU-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- 229960000458 Allantoin Drugs 0.000 description 1
- 229940069521 Aloe Extract Drugs 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
- 229960004543 Anhydrous Citric Acid Drugs 0.000 description 1
- TZCXTZWJZNENPQ-UHFFFAOYSA-L Barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
- GLQBXSIPUULYOG-UHFFFAOYSA-M Bismuth oxychloride Chemical compound Cl[Bi]=O GLQBXSIPUULYOG-UHFFFAOYSA-M 0.000 description 1
- 229940048851 CETYL RICINOLEATE Drugs 0.000 description 1
- 229960003563 Calcium Carbonate Drugs 0.000 description 1
- DSSYKIVIOFKYAU-UHFFFAOYSA-N Camphor Chemical compound C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 description 1
- 229960000846 Camphor Drugs 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 229940106189 Ceramides Drugs 0.000 description 1
- 229940056318 Ceteth-20 Drugs 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 240000005497 Cyamopsis tetragonoloba Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 229940099371 DIACETYLATED MONOGLYCERIDES Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N Diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N Dodecanol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 241000280258 Dyschoriste linearis Species 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical group CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229940044949 Eucalyptus oil Drugs 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229960002217 Eugenol Drugs 0.000 description 1
- 240000007842 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DVROLKBAWTYHHD-UHFFFAOYSA-N Hydroxy propyl distarch phosphate Chemical compound OC1C(O)C(OC)OC(CO)C1OC(O)CCOC1C(OC2C(C(O)C(OC3C(C(OP(O)(=O)OC4C(C(O)C(OC)OC4CO)O)C(C)OC3CO)O)OC2COC2C(C(O)C(OC)C(CO)O2)O)O)OC(CO)C(OC)C1O DVROLKBAWTYHHD-UHFFFAOYSA-N 0.000 description 1
- 229940078545 ISOCETYL STEARATE Drugs 0.000 description 1
- 229940093629 ISOPROPYL ISOSTEARATE Drugs 0.000 description 1
- NNPPMTNAJDCUHE-UHFFFAOYSA-N Isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 1
- QWTDNUCVQCZILF-UHFFFAOYSA-N Isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 1
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 1
- 238000003109 Karl Fischer titration Methods 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 229940048866 LAURAMINE OXIDE Drugs 0.000 description 1
- 229960004873 LEVOMENTHOL Drugs 0.000 description 1
- SXQFCVDSOLSHOQ-UHFFFAOYSA-N Lactamide Chemical compound CC(O)C(N)=O SXQFCVDSOLSHOQ-UHFFFAOYSA-N 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N Lauryldimethylamine oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229940105112 MAGNESIUM MYRISTATE Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L Magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 229940041616 Menthol Drugs 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- GLENXXAWVZPRJI-UHFFFAOYSA-N N-propyldodecan-1-amine;sodium Chemical compound [Na].CCCCCCCCCCCCNCCC GLENXXAWVZPRJI-UHFFFAOYSA-N 0.000 description 1
- 210000000282 Nails Anatomy 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- YWQYNEQVRXBSKD-UHFFFAOYSA-N OF.OP(O)(O)=O Chemical compound OF.OP(O)(O)=O YWQYNEQVRXBSKD-UHFFFAOYSA-N 0.000 description 1
- 229940101267 Panthenol Drugs 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- DNMNDNSFJMUUFM-UHFFFAOYSA-N Prussian blue Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N.N#C[Fe-4](C#N)(C#N)(C#N)(C#N)C#N DNMNDNSFJMUUFM-UHFFFAOYSA-N 0.000 description 1
- 229940079889 Pyrrolidonecarboxylic Acid Drugs 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229940043230 Sarcosine Drugs 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 229940095696 Soap Product Drugs 0.000 description 1
- 229940045998 Sodium Isethionate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M Sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M Sodium stearate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229940034610 Toothpaste Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 229940046009 Vitamin E Drugs 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 1
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2S,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 description 1
- YYDZACXIVKPEAI-ZPHPHTNESA-N [(Z)-octadec-9-enyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC YYDZACXIVKPEAI-ZPHPHTNESA-N 0.000 description 1
- WMOBLRURFXZUMY-MSUUIHNZSA-N [(Z)-octadec-9-enyl] tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC WMOBLRURFXZUMY-MSUUIHNZSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DHFCLYNGVLPKPK-UHFFFAOYSA-N acetamide;2-aminoethanol Chemical compound CC(N)=O.NCCO DHFCLYNGVLPKPK-UHFFFAOYSA-N 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005452 alkenyloxyalkyl group Chemical group 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 150000001343 alkyl silanes Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000005466 alkylenyl group Chemical group 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000845 anti-microbial Effects 0.000 description 1
- 229940053200 antiepileptics Fatty acid derivatives Drugs 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- OPVLOHUACNWTQT-UHFFFAOYSA-N azane;2-dodecoxyethyl hydrogen sulfate Chemical compound N.CCCCCCCCCCCCOCCOS(O)(=O)=O OPVLOHUACNWTQT-UHFFFAOYSA-N 0.000 description 1
- FMBMJZOGMAKBLM-UHFFFAOYSA-N azane;sulfo dodecanoate Chemical compound [NH4+].CCCCCCCCCCCC(=O)OS([O-])(=O)=O FMBMJZOGMAKBLM-UHFFFAOYSA-N 0.000 description 1
- 239000010428 baryte Substances 0.000 description 1
- 229910052601 baryte Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229910001570 bauxite Inorganic materials 0.000 description 1
- 229940106010 beheneth-25 Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- MKHVZQXYWACUQC-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;dodecyl sulfate Chemical compound OCCNCCO.CCCCCCCCCCCCOS(O)(=O)=O MKHVZQXYWACUQC-UHFFFAOYSA-N 0.000 description 1
- IUGNTDSUZLPSOK-UHFFFAOYSA-N bis(4-methylpentyl) hexanedioate Chemical compound CC(C)CCCOC(=O)CCCCC(=O)OCCCC(C)C IUGNTDSUZLPSOK-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 229930007890 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 230000001010 compromised Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005824 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 239000010431 corundum Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KBODESQIOVVMAI-UHFFFAOYSA-N decyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCC KBODESQIOVVMAI-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000001066 destructive Effects 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecan-1-amine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000001804 emulsifying Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 239000010433 feldspar Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000010436 fluorite Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M glycolate Chemical class OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000010438 granite Substances 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (Z,12R)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 1
- WUKXMJCZWYUIRZ-UHFFFAOYSA-N hexadecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(C)O WUKXMJCZWYUIRZ-UHFFFAOYSA-N 0.000 description 1
- TZMQHOJDDMFGQX-UHFFFAOYSA-N hexane-1,1,1-triol Chemical compound CCCCCC(O)(O)O TZMQHOJDDMFGQX-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- YDZQQRWRVYGNER-UHFFFAOYSA-N iron;titanium;trihydrate Chemical compound O.O.O.[Ti].[Fe] YDZQQRWRVYGNER-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003522 irritant Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-L itaconate(2-) Chemical compound [O-]C(=O)CC(=C)C([O-])=O LVHBHZANLOWSRM-UHFFFAOYSA-L 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000002045 lasting Effects 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 239000011776 magnesium carbonate Substances 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008204 materials by function Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000003020 moisturizing Effects 0.000 description 1
- 239000002365 multiple layer Substances 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N oxo-oxoalumanyloxy-[oxo(oxoalumanyloxy)silyl]oxysilane;dihydrate Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 125000000963 oxybis(methylene) group Chemical group [H]C([H])(*)OC([H])([H])* 0.000 description 1
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000011528 polyamide (building material) Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- CMDGQTVYVAKDNA-UHFFFAOYSA-N propane-1,2,3-triol;hydrate Chemical compound O.OCC(O)CO CMDGQTVYVAKDNA-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 229910052904 quartz Inorganic materials 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000005619 secondary aliphatic amines Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 description 1
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 1
- XZZDWCJZCAQFDF-UHFFFAOYSA-N sodium;tridecyl benzenesulfonate Chemical compound [Na].CCCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 XZZDWCJZCAQFDF-UHFFFAOYSA-N 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 229910052950 sphalerite Inorganic materials 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 230000003068 static Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-M stearate Chemical class CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000006277 sulfonation reaction Methods 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical class [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- QHGNHLZPVBIIPX-UHFFFAOYSA-N tin(II) oxide Inorganic materials [Sn]=O QHGNHLZPVBIIPX-UHFFFAOYSA-N 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 239000011031 topaz Substances 0.000 description 1
- 229910052853 topaz Inorganic materials 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N α-Methylstyrene Chemical group CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
Abstract
The present invention relates to a mild body wash composition containing a surfactant component containing a nonionic surfactant having an HLB of from about 1.5 to 13.0, an anionic surfactant, an electrolyte;and the surfactant component has a structured domain.
Description
SOFT LIQUID SOAP FOR THE BODY
FIELD OF THE INVENTION
The present invention relates to a body-gentle liquid soap composition comprising a surfactant component comprising at least one non-ionic surfactant having a hydrophilic-lipophilic balance of about 1.5 to 13.0, at least one anionic surfactant, electrolyte; and wherein said surfactant component has an opaque structured domain.
BACKGROUND OF THE INVENTION
Composition products for personal care such as liquid body soaps are becoming increasingly popular in the United States.
United and around the world. The compositions desired for body washing must meet a number of criteria. For example, to be acceptable to consumers, a liquid soap composition for the body must exhibit good cleaning properties, exhibit good foaming characteristics, be gentle to the skin (without drying or irritate the skin) and preferably also Provide a conditioning benefit to the skin. Compositions for washing the body that attempt to provide conditioning benefits are known. Many of these compositions are aqueous systems comprising an emulsifying conditioning oil or other similar materials in combination with a foaming surfactant. Although these products provide both conditioning and cleaning benefits, it is often difficult to formulate a product that deposits a sufficient amount of skin conditioning agents on it during use. To combat the emulsification of the skin conditioning agents by the cleansing surfactant, large amounts of the skin conditioning agent are added to the compositions. However, this introduces another problem associated with these cleaning products and conditioners. Raising the level of the skin conditioning agent to achieve better deposit negatively affects the foaming performance and stability of the product. Accordingly, the need persists for a stable composition of mild body soap that provides longer lasting cleaning of the foam and better foaming characteristics and benefits for the skin such as silky feel of the skin, better smooth feeling of the skin, and better smooth feeling of the skin. It is therefore an object of the present invention to provide a liquid soap composition for the body comprising surfactants having a structured phase which can be combined with high levels of skin conditioning materials which are emulsified in the composition and are preferably suspended from the skin. such that skin conditioning materials can be deposited at higher levels while at the same time maintaining superior performance against conventional liquid body soaps.
BRIEF DESCRIPTION OF THE INVENTION
The present invention relates to a body-gentle liquid soap composition comprising a surfactant component comprising at least one non-ionic surfactant having a hydrophilic-lipophilic balance of about 1.5 to 13.0, at least one anionic surfactant, an electrolyte; and wherein said surfactant component has an opaque structured domain. The present invention further relates to a multi-phase composition of mild liquid soap for the body comprising at least two visually distinct phases; where the phases form a pattern; wherein said composition comprises a surfactant component comprising a nonionic surfactant having a hydrophilic-lipophilic balance of about 3.4 to 13.0; an anionic surfactant; an electrolyte; and wherein said composition has a structured domain; and wherein said phases are packaged in direct physical contact with each other and maintain their stability. The present invention is also directed to a method for cleaning, moisturizing and supplying beneficial agents for the skin and particles by applying a composition to the skin as described above.
DETAILED DESCRIPTION OF THE INVENTION
The body-gentle liquid soap composition of the present invention comprises a surfactant component comprising a non-ionic surfactant having a hydrophilic-lipophilic balance of about 1.5 to 13.0, an anionic surfactant, an electrolyte; and wherein said composition comprises a structured domain. These and other essential limitations of the compositions and methods of the present invention, as well as many of the optional ingredients suitable for use herein are described in detail below. The term "anhydrous", as used herein and unless otherwise specified, refers to compositions or materials containing less than about 10%, more preferably less than about 5%, even more preferably about 3. %, even more preferably zero percent, by weight of water. The term "environmental conditions", as used herein, refers to the surrounding conditions at 101 kPa ((1) atmosphere) of pressure, 50% relative humidity, and 25 ° C. As used herein, the term "cosmetically effective concentration" is a concentration that confers a benefit during the use of the composition.
As used herein, the term "consistency value" or "k" is a measure of the viscosity and is used in combination with the cutting index to determine the viscosity of the materials in which the viscosity is a function of the friction. The measurements are made at 25 ° C and the units are poise (equal to 0.1 Pa.s (100 centipoise)). The term "hydrophobically modified interference pigment" or "HMIP", as used herein, means that a portion of the surface of the interference pigment has been coated, including both the physical and chemical bonding of the molecules, with a material hydrophobe. As used herein, "domain" means a volume of material, component, composition or phase comprising a molecular mixture that can be concentrated but can not be further separated by physical forces such as ultracentrifugation. For example, lamellar surfactant, micellar surfactant, crystalline surfactant, oil, wax, water-glycerin mixture, and hydrophilic hydrated polymer, all constitute domains that can be concentrated and observed by ultracentrifugation, but can not be further separated into separate molecular components by the same forces. As used herein, "interference pigment" refers to a pearlescent pigment that is prepared by coating the surface of a particulate substrate material (generally platelet-shaped) with a thin film. The thin film is a transparent or semi-transparent material that has a high refractive index. The material having a high refractive index exhibits a pearl luster resulting from the interference action between the reflecting light and the incident light from the contact surface between the platelet substrate and the coating layer and the reflectance of the incident light from the surface of the coating layer. As used herein, the terms "multiphase" or "multi-phase" refer to the fact that the two or more phases in the present occupy separate but distinct physical spaces within the container in which they are stored, but which are in direct contact between yes (that is, they are not separated by a barrier and are not emulsified or mixed at a considerable level). In a preferred embodiment of the present invention, "multiphase" personal care compositions comprising at least two phases are present within the container as a visually distinct pattern. The pattern is obtained by mixing or homogenizing the "multiphase" composition. The patterns include, but are not limited to, the following examples: striped, marbled, rectilinear, dashed, checkered, mottled, veined, cluster, mottled, geometric, polka dots, strips, helical, swirling, in series, mottled, textured, grooved, flanged, wavy, sinusoidal, spiral, twisted, curved, cyclic, with lines, fluted, contoured, anisotropic, cordoned, woven or interwoven, reticulated, with spots and in the form of mosaics. Preferably, the pattern is selected from the group comprising striped, geometric, marbled and combinations thereof. In a preferred embodiment, the striped pattern can be relatively uniform and even in the entire dimension of the package. Alternatively, the striped pattern may be uneven, i.e. wavy or have a non-uniform dimension. The striped pattern does not necessarily extend through the entire dimension of the container. The phases can be of several different colors or can include particles, brightness or a pearly tone. The term "a body-gentle liquid soap composition" as used herein, refers to compositions intended for topical application to the skin or hair. The term "opaque" structured domain as used herein, refers to a surfactant domain with ordered structures (eg, lamellar structure, vesicular structure, cubic structure, etc.) and is visually opaque to the naked eye in a plastic centrifuge tube with an inner diameter of 10 mm according to the ultracentrifugation method described herein. As used herein, the term "phases" refers to a region of a composition having an average composition, as opposed to another region having a different average composition, wherein the regions can be observed with the naked eye. This would not exclude that the different regions comprise two similar phases wherein one phase would comprise pigments, dyes, particles, and various optional ingredients, and therefore a region or domain of a different average composition. As used herein, "cutting index" or "n" refers to a measure of the viscosity and is used in combination with the consistency value to define the viscosity of the materials in which the viscosity is a function of the friction. The measurements are made at 25 ° C and the units have no dimension. The term "stable", as used herein, unless otherwise specified, refers to compositions that maintain at least two "separate" phases when placed in physical contact under environmental conditions for a period of time. at least 180 days, where the distribution of the two phases in different places in the container does not change over time. By "separate" it means that the well-distributed nature of the visually distinct phases is compromised, so that the larger regions of at least one phase are collected to compromise the dispatched and balanced relationship of two or more compositions in relation to each other. yes. As used herein, the phrase "practically free from" means that the composition comprises up to about 3%, preferably up to about 1%, more preferably up to about 0.5%, even more preferably up to about 0.25% and most preferably to about 0.1% of the indicated ingredient, by weight of the composition. As used herein, the Vaughan solubility parameter (VSP) is a parameter that defines the solubility of the hydrophobic compositions comprising the hydrophobic materials. The Vaughan solubility parameters are well known in the various chemical and formulation techniques, and typically have a range of about 5 to about 25 (cal / cm 3) 1/2. All percentages, parts and proportions, as used herein, are expressed by weight of the total composition unless otherwise indicated. With respect to the listed ingredients, all of these weights are based on the level of asset and therefore do not include solvents or by-products that may otherwise be included in commercially available products., unless otherwise specified. The soft body liquid soap compositions and methods of the present invention may comprise, consist of, or consist essentially of, the essential elements and limitations of the invention described herein, as well as any additional or optional ingredients or components, or the limitations described herein or otherwise useful in personal care compositions intended for topical application to hair or skin. Product form The soft body soap composition of the present invention is normally in liquid form. In this document, the term "liquid" means that the composition has a certain degree of fluidity. Therefore, the term "liquids" may include liquid, semi-liquid, cream, lotion or gel compositions, which are intended to be applied topically on the skin. The compositions typically exhibit a viscosity of equal to or greater than about 1.5 Pa.s (1,500 cps) to about 1000 Pa.s (1,000,000 cps), as measured by the Viscosity Method as described in the co-pending patent application. from the USA no. No. 60 / 542,710 filed February 6, 2004. When evaluating a body-gentle liquid soap composition comprising a surfactant component and additional beneficial components, liquid body soap can be separated by a separating means, including centrifugation, ultracentrifugation, pipetting, filtering, washing, dilution, or combinations of these; Then, the separated components can be evaluated. Preferably, the separation means is selected such that the resulting separate components or phases being evaluated are not destroyed, but are representative of the component as it exists in the body-gentle liquid soap composition. If the composition is multi-phase and the phases are combined, each phase can be separated by centrifugation, ultracentrifugation, pipetting, filtering, washing, dilution, or combinations thereof, and then the separated phases can be evaluated. All forms of the product considered to define the compositions and methods of the present invention are formulations that are removed by rinsing, which means that the product is applied topically to the skin or hair where it is rinsed almost immediately (it is say a few minutes later) with water or in any other way is cleaned with a substrate or other suitable means of disposal by depositing a portion of the composition.
SURFACTANT COMPONENT The soft body liquid soap composition of the present invention comprises a surfactant component comprising a surfactant or a mixture of surfactants. The surfactant component comprises surfactants suitable for application to the skin or hair. The general categories of alkylamines and alkanolamines are less preferred surfactants, because these surfactants tend to be less mild than other suitable surfactants. In a preferred embodiment of the present invention, the soft body liquid soap composition is practically free of alkylamines and alkanolamines. Surfactants suitable for use herein include any known suitable cleaning surfactant or in any other way effective to be applied to the skin, and which is otherwise compatible with the other essential ingredients in the body-gentle liquid soap composition including water . These surfactants include nonionic, cationic, zwitterionic or amphoteric anionic surfactants, soap or combinations thereof. Preferably, the surfactant component comprises a mixture of at least one nonionic surfactant, at least one anionic surfactant and at least one amphoteric surfactant. In a preferred embodiment, the soft body liquid soap composition is practically free of a polysiloxane. The surfactant component in the present invention exhibits non-Newtonian pseudoplastic behavior. Preferably, the soft body liquid soap composition has a viscosity greater than about 1.5 Pa.s (1500 centipoise ("cps")), more preferably greater than about 5 Pa.s (5000 cps), even with more a greater preference of about 10 Pa.s (10,000 cps), even more preferably greater than about 20 Pa.s (2000 cps), as measured by the viscosity method described in the co-pending US patent application. no. series 60 / 542,710 filed on February 6, 2004. The surfactant component comprises an opaque structured domain comprising a structured surfactant system. The opaque structured domain allows the incorporation of high levels of beneficial components that are emulsified in the composition, preferably being suspended so that the beneficial components can be deposited at higher levels. The opaque structured domain is preferably a lamellar phase. The lamellar phase produces a network of lamellar gel that is a type of colloidal system. The lamellar phase provides resistance to cutting, adequate performance to suspend particles and droplets and at the same time provides long-term stability, since they are thermodynamically stable. The lamellar phase obtains a higher viscosity without the need for viscosity modifiers. Preferably, the surfactant component has a yield point greater than about 0.1 Pascal (Pa), more preferably greater than about 0.5 Pascal, still more preferably greater than about 1.0 Pascal, still more preferably greater than about 2.0 Pascal, yet more preferably greater than about 5 Pascal, and still more preferably greater than about 10 Pascal as measured by the yield point methodology described below. The body-gentle liquid soap composition comprising a surfactant component has a structured domain-volume ratio of at least about 70%, preferably at least about 75%, more preferably at least about 80%, even with more preferably at least about 85% as measured by the Ultracentrifugation Method described below. The soft body liquid soap composition preferably comprises a surfactant component in concentrations in a range of about 1% to about 95%, preferably 5% to about 95%, more preferably from about 25% to about 90%, even more preferably from about 35% to about 88%, even more preferably from about 40% to about 85%, and even more preferably from about 45% to about 85% by weight of the composition of liquid soap for the body. The surfactant component comprises the surfactant in concentrations in a range of about 8% to -50%, preferably about 10% to about 35%, preferably about 12% to about 30%, more preferably about 14% to about 24.5% , and even more preferably about 20% to about 24%. The preferred pH range of the liquid soap for the body is from about 5 to about 8, more preferably about 6. In a preferred embodiment of the present invention, the soft body liquid soap composition is a soft multi-liquid soap. phases comprising at least two visually distinct phases; wherein at least one phase is a cleaning phase; wherein said cleaning phase comprises a surfactant component comprising a surfactant or a mixture of surfactants. When the surfactant component is present in the multiphase composition for personal care, the surfactant component comprises a structured domain that allows the incorporation of. high levels of beneficial components in a visually distinct phase that are not emulsified in the composition but are suspended. The structured domain of preference is an opaque structured domain. The opaque structured domain is preferably a lamellar phase. The multiphase composition comprising the surfactant component has a structured-volume domain ratio of at least about 45%, preferably at least about 50%, more preferably at least about 55%, even more preferably at least about 60%, still more preferably at least about 65%, even more preferably at least about 70%, even more preferably at least about 80% as measured by the Ultracentrifugation Method described below. Nonionic Surfactants The soft liquid body soap composition preferably comprises at least one nonionic surfactant. Preferably the nonionic surfactant has a hydrophilic-lipophilic balance of about 1.5 to 13.0, preferably about 3.4 to 13.0, more preferably 3.4 to about 9.5, more preferably 3.4 to about 5.0. The soft body liquid soap composition preferably comprises a nonionic surfactant in concentrations in a range of from about 0.1% to about 50%, more preferably from about 0.25% to about 30%, even more preferably about 0.5% a about 25%, still more preferably from about 1.0% to about 20%, even more preferably from about 1.5% to about 10%, by weight of the surfactant component. Non-limiting examples of nonionic surfactants useful in the compositions of the present invention are described in McCutcheon's Detergents and Emulsifiers, US edition. (1986) published by Allured Publishing Corporation, and in Functional Materials, McCutcheon, edition for the USA. (1992).
The nonionic foaming surfactants useful herein include those selected from the group comprising alkyl glycosides, alkyl polyglucosides, polyhydroxy fatty acid amides, alkoxylated fatty acid esters, sucrose foam esters, amine oxides, and mixtures thereof. Non-limiting examples of preferred nonionic surfactants for use herein are those selected from the group comprising C8-C glucosamides? , C8-C14 alkyl polyglucosides, sucrose cocoate, sucrose laurate, and mixtures thereof. In a preferred embodiment the nonionic surfactant is selected from the group comprising glyceryl monohydroxystearate, steareth-2, hydroxystearic acid, propylene glycol stearate, PEG-2 stearate, sorbitan monostearate, glyceryl stearate, laureth-2 and mixtures thereof. In a preferred embodiment the non-ionic surfactant is steareth-2. Nonionic foaming surfactants also useful herein include, lauramine oxide, cocoamine oxide. The balance between the hydrophilic and lipophilic entities in a surfactant molecule is used as a classification method (hydrophilic-lipophilic balance, HLB). HLB values for commonly used surfactants are available in the literature (eg, HLB Index (HLB index) in McCutcheon's Emulsifiers and Detergents, MC Publishing Co., 2004). For example in industry it is known that cocamide monoethanolamine (CMEA) has an HLB value of 16.8. Another way to obtain the HLB values is to make an estimate using calculations. The HLB system was originally conceived by Griffin (J. Soc. Cosmetic Chem., 1, 311, 1949). Griffin defines the HLB value of a surfactant as the mole percent of hydrophilic groups divided by 5, where one totally hydrophilic molecule (no non-polar groups) had an HLB value of 20. Other examples of how to calculate HLB values are described by Davies in Interfacial Phenomena (Interiacial Phenomena), Second Edition, Academic Press, London, 1963, and by Lin in J. Phys. Chem. 76, 2019-2013, 1972. Anionic Surfactants: The composition of mild liquid body soap preferably comprises at least one anionic surfactant. The soft body liquid soap composition preferably comprises an anionic surfactant in concentrations ranging from about 1% to about 50%, more preferably from about 4% to about 30%, even more preferably from about 5% to about 25%, by weight of the surfactant component. Preferably the anionic surfactants are selected from the group comprising alkyl ether sulphates, alkylsulfonates and mixtures thereof. Suitable anionic surfactants for use in the body mild liquid soap composition include alkyl sulfates and alkyl ether sulfates. These materials have the respective formula ROSO3M and RO (C2H4O) xSO3M, wherein R is alkyl or alkenyl of about 8 to about 24 carbon atoms, x is 1 to 10, and M is a water soluble cation such as ammonium, sodium, potassium and triethanolamine. Alkylether sulfates are usually made as condensation products of ethylene oxide and monohydric alcohols having from about 8 to about 24 carbon atoms. Preferably, R has from about 10 to about 18 carbon atoms in both alkyl sulfates and alkyl ether sulfates. The alcohols can be derived from fats, for example coconut oil or tallow, or they can be synthetic. In the present invention, lauryl alcohol and straight chain alcohols derived from coconut oil are preferred. These alcohols are reacted with from about 1 to about 10, preferably from about 3 to about 5, and more preferably with about 3 molar proportions of ethylene oxide and the resulting mixture of the molecular species having, for example, an average of 3. moles of ethylene oxide per mole of alcohol, sulfated and neutralized. Specific examples of alkyl ether sulfates that can be used in the composition of mild liquid soap for the body are the sodium and ammonium salts of alkyl triethylene glycol ether coconut sulfate; alkyl triethylene glycol ether tallow sulfate, and alkyl hexoxyethylene sulphate tallow. The most preferred alkyl ether sulfates are those comprising a mixture of individual compounds; the mixture has an average alkyl chain length of about 10 to about 16 carbon atoms and an average degree of ethoxylation of about 1 to about 4 moles of ethylene oxide.
Other suitable anionic surfactants include the water soluble salts of the organic products of the reaction with sulfuric acid corresponding to the general formula [R1-S03-M], wherein R1 is selected from the group comprising a saturated aliphatic hydrocarbon radical of chain linear or branched having from about 8 to about 24, preferably from about 10 to about 18 carbon atoms, and M is a cation. Suitable examples are the salts of a reaction product of organic sulfuric acid of a hydrocarbon of the methane series, including iso, neo, ineso, and n-paraffins having from about 8 to about 24 carbon atoms, preferably from about 10 to about 18 carbon atoms and a sulfonating agent, for example SO3, H2SO, oleum, obtained according to known methods of sulfonation, including bleaching and hydrolysis. Preferred are sulfonated C10-18 n-paraffins of alkali metals and ammonium. Other suitable surfactants are described in the publication
McCutcheon's, Emulsifiers and Deterqents, 1989 Annual, published by M. C. Publishing Co., and in U.S. Pat. no. 3,929,678. Preferred anionic surfactants for use in the body mild liquid soap composition include ammonium laurisulfate, ammonium laureth sulfate, triethylamine laurisulfate, triethylamine laureth sulfate, triethanolamine lauryl sulfate, triethanolamine laureth sulfate, monoethanolamine laurisulfate, monoethanolamine laureth sulfate, Diethanolamine lauryl sulfate, diethanolamine laureth sulfate, monoglyceride sodium lauryl sulfate, sodium laurisulfate, sodium laureth sulfate, potassium laureth sulfate, sodium lauryl sarcosinate, sodium lauroyl sarcosinate, lauryl sarcosine, cocoyl sarcosine, ammonium cocoyl sulfate, ammonium lauroyl sulfate, sodium cocoyl sulfate , sodium lauroylsulfate, potassium cocoylsulfate, potassium laurisulfate, monoethanolamine cocoylsulfate, sodium tridecylbenzenesulfonate, sodium dodecylbenzenesulfonate, and combinations thereof. In some embodiments, anionic surfactants with branched alkyl chains, such as sodium trideceth sulfate, are preferred. In some embodiments, mixtures of anionic surfactants can be used. Amphoteric Surfactants In some embodiments of the soft body liquid soap compositions of the present invention preferably may further comprise an amphoteric surfactant, a zwitterionic surfactant and mixtures thereof. In one embodiment, the soft body liquid soap composition may preferably further comprise at least one amphoteric surfactant. The soft body liquid soap composition preferably comprises an amphoteric surfactant in concentrations ranging from about 1% to about 50%, more preferably from about 2% to about 30%, even more preferably from about 3% to about 25%, by weight of the surfactant composition. Amphoteric surfactants suitable for use in the present invention include those which are generally described as derivatives of secondary and tertiary aliphatic amines in which the aliphatic radical can be straight or branched chain and wherein one of the aliphatic substituents contains about 8 to about 18 carbon atoms and one contains an anionic group for solubilization in water, e.g. ex. carboxyl, sulfonate, sulfate, phosphate, or phosphonate. Examples of compounds falling within this definition are: 3-dodecilminopropionato, sodium 3-dodecylaminopropane, sodium lauryl sarcosinate, N-alkyltaurines such as the one prepared by reacting dodecylamine with sodium isethionate according the teachings of the U.S. patent no. 2,658,072, N-higher alkyl aspartic acids such as those made according to the teachings of U.S. Pat. no. 2,438,091, and the products described in U.S. Pat. no. 2,528,378. The amphoacetates and dianfoacetates can also be used. Anfoacetate
CH3 (CH2) nCOHNHCH2N-CH2CH2OH I
CH2COO "M + Dianfoacetato
CH2COO 'M + I RCONCH2CH2N - CH2CH2OH
CH2COO- M +
The amphoacetates and the dianfoacetates conform to the formulas (mentioned above) wherein R is an aliphatic group of 8 to 18 carbon atoms. M is a cation such as sodium, potassium, ammonium, or substituted ammonium. In some embodiments, sodium lauroamphoacetate, sodium cocoamphoacetate, disodium lauroamphoacetate, and disodium cocodyamphoacetate are preferred. Additional surfactants of the zwitterionic surfactant classes, and / or cationic surfactants can be incorporated into the soft body soap compositions. In one embodiment, the soft body liquid soap composition may preferably further comprise at least one zwitterionic surfactant. The soft body liquid soap composition preferably comprises a zwitterionic surfactant in concentrations ranging from about 1% to about 50%, more preferably from about 2% to about 30%, even more preferably from about 3% to about 25%, by weight of the surfactant composition. Zwitterionic surfactants suitable for use in mild body soap compositions include those generally described as derivatives of quaternary aliphatic ammonium, phosphonium, and sulfonium compounds, in which the aliphatic radicals may be straight or branched chain , and wherein one of the aliphatic substituents contains from about 8 to about 18 carbon atoms and one contains an anionic group, e.g. ex. carboxyl, sulfonate, sulfate, phosphate, or phosphonate. These suitable zwitterionic surfactants can be represented by the formula:
(R3) x L R2- Y + -CH2-R4- Z
wherein R2 contains an alkyl, alkenyl or hydroxyalkyl radical of from about 8 to about 18 carbon atoms, from 0 to about 10 ethylene oxide entities and from 0 to about 1 glyceryl entity; And it is chosen from the group comprising nitrogen, phosphorus and sulfur atoms; R3 is an alkyl or monohydroxyalkyl group containing from about 1 to about 3 carbon atoms; X is 1 when Y is a sulfur atom and 2 when Y is a nitrogen or phosphorus atom; R 4 is an alkylene or hydroxyalkylene of about 1 to about 4 carbon atoms and Z is a radical selected from the group comprising carboxylate, sulfonate, sulfate, phosphonate and phosphate groups. Other zwitterionic surfactants suitable for use in mild body soap compositions include betaines, including the high alkyl betaines such as cocodimethyl carboxymethyl betaine, cocoamidopropyl betaine, cocobetaine, laurylamidopropyl betaine, oleylbetaine, lauryldimethyl carboxymethyl betaine, lauryldimethyl alphacarboxyethyl betaine, cetyldimethyl carboxymethyl betaine , lauryl bis- (2-hydroxyethyl) carboxymethyl betaine, stearyl bis- (2-hydroxypropyl) carboxymethyl betaine, oleyldimethyl gylcarboxypropyl betaine, and lauryl bis- (2-hydroxypropyl) alpha-carboxyethyl betaine. Sulfobetaines which can be represented by coconut dimethyl sulfopropyl betaine, stearyldimethyl sulfopropyl betaine, lauryl dimethyl sulfoethyl betaine, lauryl bis- (2-hydroxyethyl) sulfopropyl betaine and the like, amidobetaines and amidosulfobetaines, wherein the radical RCONH are also useful in this invention. (CH2) 3 is attached to the nitrogen atom of betaine. Cationic surfactants can also be used in mild body soap compositions, but are generally less preferred, and preferably represent less than about 5% by weight of the compositions. Electrolyte If an electrolyte is used, it can be added per se in the composition or it can be formed in place by means of the counterions included in some raw material. The electrolyte preferably includes an anion comprising phosphate, chloride, sulfate or citrate and a cation comprising sodium, ammonium; potassium, magnesium or mixtures of these. Some preferred electrolytes are sodium or ammonium chloride or sodium or ammonium sulfate. A preferred electrolyte is sodium chloride. The electrolyte is preferably added to the surfactant component of the composition. When present, the electrolyte must be present in an amount that facilitates the formation of the stable composition (non-Newtonian pseudoplastic behavior). In general, this amount is from about 0.1% by weight to about 15% by weight, preferably from about 1% to about 6% by weight of the composition, but can be varied if required. Beneficial Component The soft body soap compositions of the present invention may comprise a beneficial component. The beneficial component is selected from the group comprising lipids, hydrocarbons, fats, oils, hydrophobic plant extracts, fatty acids, essential oils, silicone materials and mixtures thereof; skin care assets, wherein the skin care assets are selected from the group comprising vitamins and their derivatives; sun protection agents; conservatives; anti-acne medications; antioxidants; agents for the relief and healing of the skin; chelating agents and sequestering agents; essential oils, sensation agents, and mixtures of these.
Hydrophobic compositions In a preferred embodiment, the soft body liquid soap compositions comprise a beneficial component comprising a hydrophobic compositions comprising a hydrophobic component. Soft body liquid soap compositions comprise from about 20% to about 100%, preferably at least about 35%, even more preferably at least about 50%, of a hydrophobic component. Hydrophobic compositions suitable for use in the present invention have a Vaughan solubility parameter, as described in the copending U.S. patent application Ser. no. serial
60 / 542,710, filed on February 6, 2004, from about 5 to about 15. The hydrophobic compositions are preferably selected from those having defined rheological properties as described in copending U.S. patent application Ser. no. of series 60 / 542,710, filed on February 6, 2004, including a selected consistency value (k) and cut index (n). These preferred rheological properties are especially useful for providing compositions of mild liquid body soap with better deposition of hydrophobic materials on the skin. In a preferred embodiment, the multi-phase compositions of mild liquid soap for the body having at least two visually distinct phases wherein at least one phase comprises a beneficial phase comprising a hydrophobic composition comprising a hydrophobic component. The beneficial phase in the preferred embodiment is anhydrous. Hydrophobic compositions suitable for use in the preferred embodiment have a Vaughan solubility parameter, as described in copending U.S. patent application Ser. no. in series 60 / 542,710, filed on February 6, 2004, from about 5 to about 15. The hydrophobic compositions are preferably selected from those having defined rheological properties as described in the co-pending US patent application. . no. of series 60 / 542,710 filed on February 6, 2004, including a selected Consistency value (k) and cut index (n). These preferred rheological properties are especially useful for improving the deposition of hydrophobic materials in the skin by the multi-phase personal care compositions. Non-limiting examples of hydrophobic components suitable for use herein may include a variety of hydrocarbons, oils and waxes, silicones, fatty acid derivatives, cholesterol, cholesterol derivatives, diglycerides, triglycerides, vegetable oils, vegetable oil derivatives, esters of acetoglycerides, alkylesters, alkenyl esters, polyglycerol fatty acid esters, lanolin and its derivatives, wax esters, beeswax derivatives, sterols and phospholipids, vitamins and provitamins and combinations thereof. Some non-limiting examples of hydrocarbon oils and waxes suitable for use in the present invention include petrolatum, mineral oil, microcrystalline wax, polyalkene, paraffins, ceresins, ozokerites, polyethylenes, perhydrosqualenes, and combinations thereof. Non-limiting examples of silicone oils suitable for use as hydrophobic components herein include dimethicone copolyol, dimethyl polysiloxane, diethyl polysiloxane, mixed C 1 -C 30 alkyl polysiloxanes, alkyl polysiloxanes, phenyl dimethicone, and combinations thereof. Non-volatile silicones selected from dimethicone, dimethiconol, combined C1-C30 alkyl polysiloxanes, and combinations thereof are preferred. Non-limiting examples of silicone oils useful herein are described in U.S. Pat. no. 5 011 681 (Ciotti et al.). Non-limiting examples of diglycerides and triglycerides suitable for use as hydrophobic components herein include castor oil, soybean oil, soybean oil derivatives such as maleated soybean oil, safflower oil, cottonseed oil, oil corn, walnut oil, peanut oil, olive oil, cod liver oil, almond oil, avocado oil, palm oil and sesame oil, vegetable oils, sunflower seed oil, and oil derivatives vegetables; coconut oil and coconut oil derivatives; cottonseed oil and cottonseed oil derivatives, jojoba oil, cocoa butter, and combinations thereof. Non-limiting examples of acetoglyceride esters suitable for use as hydrophobic components herein include acetylated monoglycerides.
Non-limiting examples of alkyl esters suitable for use as hydrophobic components herein include those isopropyl esters of fatty acids and esters of long chain fatty acids (ie C? O-C24), e.g. ex. cetyl ricinoleate, the non-limiting examples of which include isopropyl palmitate, isopropyl myristate, cetyl riconoleto and stearyl riconeleate. Other examples are: hexyl laurate, isohexyl laurate, myristyl myristate, isohexyl palmitate, decyl oleate, isodecyl oleate, hexadecyl stearate, decyl stearate, isopropyl isostearate, diisopropyl adipate, diisohexyl adipate, adipate of dihexyldecyl, diisopropyl sebacate, acyl isononanoate lauryl lactate, myristyl lactate, cetyl lactate, and combinations thereof. Non-limiting examples of alkenyl esters suitable for use as hydrophobic components herein include oleyl myristate, oleyl stearate, oleyl oleate, and combinations thereof. Non-limiting examples of polyglyceryl esters of fatty acids suitable for use as hydrophobic components herein include decaglyceryl distearate, decaglyceryl diisostearate, decaglyceryl monomiriate, decaglyceryl monolaurate, hexaglyceryl monoleate, and combinations thereof. Non-limiting examples of lanolin and lanolin derivatives suitable for use as hydrophobic components herein include lanolin, lanolin oil, lanolin wax, lanolin alcohols, lanolin fatty acids, isopropyl lanolate, acetylated lanolin, acetylated lanolin alcohols , lanolin alcohol linoleate, lanolin alcohol riconeleate, and combinations thereof. Still other suitable hydrophobic components include milk triglycerides (eg, hydroxylated milk glyceride) and polyol fatty acid polyesters. Still other suitable hydrophobic components include wax esters, the non-limiting examples of which include beeswax and beeswax derivatives, spermaceti, myristyl myristate, stearyl stearate, and combinations thereof. Vegetable waxes such as carnauba and candelilla waxes are also useful; sterols such as cholesterol, cholesterol fatty acid esters; and phospholipids such as lecithin and its derivatives; sphingolipids, ceramides, glycosphingos lipids, and combinations of these. In a preferred embodiment, the soft body liquid soap compositions may comprise a multiphase composition having a beneficial phase; wherein the beneficial phase may preferably comprise one or more hydrophobic components, wherein at least 20% by weight of the hydrophobic components are selected from petrolatum, mineral oil, sunflower seed oil, microcrystalline waxes, paraffins, ozokerite, polyethylene , polybutene, polydecene and pericyroesqualene dimethicones, cyclomethicones, alkyl siloxanes, polymethylsiloxanes and methylphenylpolysiloxanes, lanolin, lanolin oil, lanolin wax, lanolin alcohols, lanolin fatty acids, isopropyl lanolate, acetylated lanolin, acetylated lanolin alcohols, linoleate lanolin alcohol, lanolin alcohol riconelate, castor oil, soybean oil, maize soya bean oil, safflower oil, cottonseed oil, corn oil, walnut oil, peanut oil, oil olive oil, cod liver oil, almond oil, avocado oil, palm oil and sesame oil, and combinations of these. More preferably, at least about 50% by weight of the hydrophobic components are selected from the groups of petrolatum, mineral oil, paraffins, polyethylene, polybutene, polydecene, dimethicones, alkyl siloxanes, cyclomethicones, lanolin, lanolin oil, wax lanolin. The remainder of the hydrophobic component is preferably selected from isopropyl palmitate, cetyl riconoleate, octyl isononanoate, octyl palmitate, isocetyl stearate, hydroxylated milk glyceride, and combinations thereof. It has also been found that the multi-phase liquid soap compositions for the body can be formulated with improved stability by equalizing the density of the cleansing phase and the beneficial phase and incorporating density modifiers in the cleansing phase and / or the beneficial phase. To further improve stability under stress conditions, such as high temperature and vibration, it is preferable to adjust the densities of the separate phases so that they are substantially equal. To achieve this, low density microspheres are added to the cleaning phase of the multi-phase composition of mild liquid body soap. The low density microspheres used to reduce the general density of the cleaning phase are particles with a density less than OJ g / cm3, preferably less than 0.2 g / cm3, more preferably less than 0.1 g / cm3, with a greater preference less than 0.05 g / cm3. The low density microspheres generally have a diameter of less than 200 μm, preferably less than 100 μm, more preferably less than 40 μm. Preferably, the density difference between the cleaning phase and the beneficial phase is less than 0.15 g / cm3, more preferably the density difference is less than 0.10 g / cm3, even more preferably the density difference is less than 0.05 g / cm3, even more preferably the difference in density is less than 0.01 g / cm3. The microspheres are produced from any suitable organic or inorganic material, compatible with use on the skin, ie, non-irritant or toxic. Preferably, the microspheres do not have a negative impact on the foam performance of the product. Expanded microspheres made of thermoplastic material are known and can be obtained, for example, according to the processes described in the patents and patent applications EP-56219, EP-348372, EP-486080, EP-320473, EP-112807 and patent of the USA no. 3,615,972. These microspheres can be produced from any non-toxic and non-irritating thermoplastic material. For example, polymers or copolymers of acrylonitrile or vinylidene chloride can be used. For example it is possible to use a copolymer containing, by weight, from 0 to 60% units derived from vinylidene chloride, from 20 to 90% units derived from acrylonitrile and from 0 to 50% units derived from a styrene monomer or acrylic, the sum of the percentages (by weight) is equal to 100. For example, the acrylic monomer is an ethyl acrylate or methyl or methacrylate. For example, the styrene monomer is alpha-methyl styrene or styrene. These microspheres may be in the dry or hydrated state. The internal cavity of the expanded hollow microspheres contains a gas, which may be a hydrocarbon, such as for example isobutane or isopentane or alternatively air. Among the hollow microspheres that can be used, special mention will be made of those marketed under the brand EXPANCEL® (expandable thermoplastic microspheres) by Akzo Nobel Company, especially those of DE (dry state) or WE (hydrated state). Examples include: Expancel® 091 DE 40 d30; Expancel® 091 DE 80 d30; Expancel® 051 DE 40 d60; Expancel® 091 WE 40 d24; Expancel® 053 DE 40 d20. Representative microspheres derived from inorganic materials include, for example, "Qcel® Hollow Microspheres" and "EXTENDOSPHERES ™ Ceramic Hollow Spheres," both available from PQ Corporation. The examples are Qcel® 300; Qcel® 6019; Qcel® 6042S. In the same way low density microspheres can be added to the cleaning phase of the present invention to improve their stability to vibration, high density materials can be added to the beneficial phase to increase their density thus having the same impact on the stability .
In the same way low density microspheres can be added to the cleaning phase of the present invention to improve its stability, high density materials can be added to the beneficial phase to increase its density thus having the same impact on the stability. The high density particles used to increase the general density of the beneficial phase are particles having a density greater than 1.1 g / cm 3, preferably greater than 1.5 g / cm 3, with a greater preference greater than 2.0 g / cm 3 and even with a greater preference greater than 2.5 g / cm3. The high density particles generally have a diameter of less than 200 μm, preferably less than 100 μm, more preferably less than 40 μm. Preferably, the high density particles are selected from inorganic materials insoluble in water, metals, metal oxides, metal alloys and mixtures thereof. Non-limiting examples include calcium carbonate, silica, clays, mica, talc, iron, zinc, copper, lead, titanium dioxide, zinc oxide, and the like. Optional Benefit Component A variety of suitable optional beneficial components can be employed in the body-gentle liquid soap composition. These beneficial components are usually those components approved for use in cosmetics and which are described in reference books such as CTFA Cosmetic Ingredient Handbook, Second Edition, The Cosmetic, Toiletries, and Fragrance Association. Cosmetics, Toiletries and Fragrances), Inc. 1988, 1992. These optional beneficial components can be used in any aspect of the compositions of the present invention, including each phase as described herein. Component optional non-limiting benefits include humectants and solutes. The personal care composition may include various humectants and solutes with a concentration ranging from about 0.1% to about 50%, preferably from about 0.5% to about 35% and more preferably from about 2% to about 20%, in weight of the composition. A preferred humectant is glycerin. A preferred water-soluble organic material is chosen from the group comprising a polyol of the structure:
R1 - O (CH2 - CR2HO) nH
wherein R1 = H, C1-C4 alkyl; R2 = H, CH3 and n = 1-200; C2-C10 alkanediols; guanidine; glycolic acid and glycolate salts (eg, ammonium and quaternary alkylammonium); lactic acid and lactate salts (eg, ammonium and quaternary alkylammonium); polyhydroxy alcohols such as sorbitol, glycerol, hexanetriol, propylene glycol, hexylene glycol and the like; polyethylene glycol; sugars and starches; sugars and starch derivatives (eg alkoxylated glucose); panthenol (including D-, L-, and forms D, L-); pyrrolidonecarboxylic acid; hyaluronic acid; monoethanolamine lactamide; monoethanolamine acetamide; urea; and ethanolamines of the general structure (HOCH2CH2) xNHy wherein x = 1-3; y = 0-2, and x + y = 3, and mixtures of these. The most preferred polyols are selected from the group comprising glycerin, polyoxypropylene (l) glycerol and polyoxypropylene (3) glycerol, sorbitol, butylene glycol, propylene glycol, sucrose, urea and triethanolamine. Preferably, nonionic polyethylene / polypropylene glycol polymers are used as skin conditioning agents. Among the polymers useful herein the following are especially preferred: PEG-2M wherein x equals 2 and n has an average value of about 2000 (PEG 2-M is also known as Poiyox WSR® N-10 of Union Carbide and as PEG-2,000); PEG-5M where x equals 2 and n has an average value of approximately 5000 (PEG 5-M is also known as Poiyox WSR® 35 and Poiyox WSR® N-80, both from Union Carbide and as PEG-5,000 and polyethylene glycol 200,000); PEG-7M where x equals 2 and n has an average value of approximately 7000 (PEG 7-M is also known as Poiyox WSR® (N-750 from Union Carbide); PEG-9M where x equals 2 and n has an average value of about 9000 (PEG 9-M is also known as Poiyox WSR® N-3333 from Union Carbide); PEG-14 M where x equals 2 and n has an average value of about 14,000 (PEG 14-M is also known as Poiyox WSR-205 and Poiyox WSR® N-3000, both from Union Carbide); and PEG-90M where x equals 2 and n has an average value of approximately 90,000. (PEG-90M is also known as Poiyox WSR®-301 from Union Carbide.) Other non-limiting examples of these optional beneficial components include vitamins and their derivatives (eg, ascorbic acid, vitamin E, tocopheryl acetate, and the like ); sun protection agents; thickening agents (eg, alkoxy polyol ester, available as Crothix from Croda); preservatives to maintain the antimicrobial integrity of the cleaning compositions; anti-acne medications (resorcinol, salicylic acid, and the like); antioxidants; agents for the relief and healing of skin agents such as aloe extract, allantoin and the like; chelating agents and sequestering agents; and agents suitable for aesthetic purposes such as fragrances, essential oils, permeating agents, pigments, pearlizing agents (eg mica and titanium dioxide), lacquers, dyes, and the like (eg nail oil, menthol, camphor, eucalyptus oil, and eugenol). In a preferred embodiment, the soft body liquid soap composition comprises at least about 0.5%, by weight of said composition, of a fragrance. Particle The composition of mild liquid soap for the body can comprise a particle. In a preferred embodiment, the multi-phase composition of mild body soap liquid may comprise a particle in at least one phase. Water-insoluble solid particles of various shapes and densities can be used. In a preferred embodiment, the shape of the particle tends to be spherical, oval, irregular or any other shape in which the ratio of length to width (defined as the aspect ratio) is up to about 10. More preferably, the dimensional proportion of the particle is up to about 8 and with an even greater preference that proportion is up to about 5. The particle of the present invention has a particle size (average volume based on the measurement of the particle size described in the co-pending U.S. Patent Application Serial No. 60 / 542,710 filed February 6, 2004) less than about 100 μm, preferably less than about 80 μm, and more preferably the particle size is less than about 60 μm. The particle of the present invention preferably has a particle size greater than about 0.1 μm, preferably a particle size greater than about 0.5 μm, more preferably a particle size greater than about 1 μm, even more preferably a particle size greater than about 2 μm, still more preferably a particle size greater than about 3 μm, and even more preferably a particle size greater than about 4 μm. The particle has a diameter of about 1 μm to about 70 μm, more preferably about 2 μm to about 65 μm, and even more preferably about 2 μm to about 60 μm in diameter. The body-gentle liquid soap composition of the present invention comprises the particle at a cosmetically effective level. Preferably the composition comprises at least about 0.1% by weight, more preferably at least about 0.2% by weight, more preferably at least about 0.5% by weight, with a greater preference at least about 1%, and with a preference still greater than at least about 2% by weight of the particles. In the soft body soap composition of the present invention, the particles preferably comprise not more than about 50% by weight of the composition, more preferably not more than about 30%, even more preferably not more than about 20%, and even more preferably not more than about 10% by weight. weight of the composition. Preferably, the particle will also have physical properties that are altered significantly during the normal processing of the composition. Preferably, a particle whose melting point is greater than about 70 ° C, more preferably greater than about 80 ° C, and even more preferably greater than about 95 ° C is used. As used herein, the melting point refers to the temperature at which the particle passes into a liquid or fluid state or undergoes significant deformation or changes in its physical properties. In addition, many of the particles of the present invention are crosslinked or have a cross-linked surface membrane. These particles do not exhibit a different melting point. Crosslinked particles are also useful as long as they are stable under the processing and storage conditions that are used in making the compositions.
The particles useful in the present invention can be natural, synthetic or semi-synthetic. In addition, hybrid particles can also be used. The synthetic particles can be obtained from crosslinked or non-crosslinked polymers. The particles of the present invention may have surface charges or their surface may be modified with organic or inorganic materials such as surfactants, polymers, and inorganic materials. Particulate complexes can be used. Examples of natural particles include various silica particles precipitated in hydrophilic or hydrophobic form available from Degussa-Huls under the trade name Sipernet. A preferred particle is Precipitated ™, hydrophobic, synthetic and amorphous silica available from Degussa under the trade name Sipernet D11 ™. The colloidal silica particles of Snowtex are available from Nissan Chemical America Corporation. Non-limiting examples of synthetic particles include nylon, silicone resins, poly (meth) acrylates, polyethylene, polyester, polypropylene, polystyrene, polyurethane, polyamide, epoxy resins, urea resins, and acrylic powders. Among the non-limiting examples of useful particles are mentioned Microease 11 OS, 114S, 116 (micronized synthetic waxes), Micropoly 210, 250S (micronized polyethylene), Microslip (micronized polytetrafluoroethylene), and Microsilk (combination of polyethylene and polytetrafluoroethylene), all available from Micro Powder, Inc. Other examples include Luna particles (soft silica particles) available from Phenomenex, MP-2200 (polymethylmethacrylate), EA-209 (ethylene / acrylate copolymer), SP-501 (nylon-12), ES -830 (polymethylmethacrylate), BPD-800, BPD-500 (polyurethane) available from Kobo Products, Inc. and silicone resins marketed as Tospearl particles by GE Silicones. The cross-linked polystyrene Ganzpearl GS-0605 (available from Presperse) is also useful. Examples of hybrid particles include Ganzpearl
GSC-30SR (Sericite and cross-linked polystyrene hybrid powder) and SM-1000, SM-200 (hybrid silica powder available from Presperse). Exfoliating particle The exfoliating particle is selected from the group comprising polyethylene, microcrystalline wax, jojoba esters, amorphous silica, talc, tricalcium orthophosphate, or mixtures thereof, and the like. The exfoliating particle has a particle size along the major axis of the particle ranging from about 100 microns to about 600 microns, preferably from about 100 microns to about 300 microns. The exfoliating particle has a hardness less than about 4 mohs, preferably less than about 3 mohs. The hardness measured in this way is a criterion of the resistance of a particulate material to crushing. It is known as a fairly adequate indicator of the abrasiveness of a particulate ingredient. Examples of materials, mentioned in order of increasing hardness in accordance with the Moh scale are: h (hardness) -1-.talk; h-2: gypsum, rock salt, crystalline salt in general, barite, chalk, native sulfur; h-4: fluorite, soft phosphate, magnesite, limestone; h-5: apatite, hard phosphate, hard limestone, chromite, bauxite; h-6: feldspar, ilmenite, homblenda; h-7: quartz, granite; h-8: topaz; h-9: corundum, emery; and h-10: diamond. Preferably, the exfoliating particle has a color different from that of the cleaning base. Preferably, the composition comprises less than about 10% and more preferably less than about 5% exfoliating particle, by weight. Glossy particles The composition of soft liquid soap for the body can comprise a bright particle. In a preferred embodiment, the multi-phase composition of mild body soap liquid may comprise a bright particle in at least one phase. Non-limiting examples of bright particles include the following: interference pigment, multilayer pigment, metallic particle, solid and liquid crystals, or combinations of these. An interference pigment is a pearl-luster pigment that is prepared by coating the surface of a particulate substrate material with a thin film. The particulate substrate material usually has a platelet shape. The thin film is a transparent or semi-transparent material that has a high refractive index. The material having a high refractive index exhibits a pearl luster resulting from the interference action between the reflecting light and the incident light from the contact surface between the platelet substrate and the coating layer and the reflectance of the incident light from the surface of the coating layer.
The interference pigments of the soft body liquid soap composition preferably comprise no more than about 20 weight percent of the composition, more preferably no more than about 10 weight percent, even more preferably no more than about 7 percent by weight, still more preferably no more than about 5 percent by weight of the composition of mild liquid soap for the body. The interference pigment of the soft body liquid soap composition preferably comprises at least about 0.1 weight percent of the soft liquid body soap composition, more preferably at least about 0.2 weight percent, yet more preferably at least about 0.5 weight percent, still more preferably at least about 1 weight percent of the composition. When the pigment is applied and rinsed as described in the method of the strip of adhesive tape to determine the deposit of pigments disclosed in co-pending application serial number 60 / 469,075 filed on May 8, 2003, the pigment deposited on the skin preferably it is at least 0.5 μg / cm2, more preferably at least 1 μg / cm2 and even more preferably at least 5 μg / cm2. The interference pigments of the present invention are particulates in platelets. Platelet particulates preferably have a thickness of not more than about 5 μm, more preferably not more than about 2 μm, even more preferably not more than about 1 μm. The platelet particulates preferably have a thickness of at least about 0.02 μm, more preferably at least about 0.05 μm, still more preferably at least about 0.1 μm, still more preferably at least about 0.2 μm. The size of the particle determines the opacity and luster. The size of the particle is determined by measuring the thickness of the diameter of the particulate material. As used herein, the term "diameter" means the greatest distance through the principal axis of the particulate material. The diameter can be determined using any suitable method known in the industry, for example the Mastersizer 2000 particle size analyzer manufactured by Malvem Instruments. The interference pigment preferably has an average diameter of not more than about 200 μm, more preferably not more than 100 μm, still more preferably not more than about 80 μm, still more preferably not more than about 60 μm. The interference pigment preferably has a diameter of at least about 0.1 μm, more preferably at least about 1.0 μm, still more preferably at least about 2.0 μm, still more preferably at least about 5.0 μm. The interference pigment may comprise a multilayer structure. The center of the particulates is a flat substrate with a refractive index (Rl) commonly lower than 1.8. A large variety of particle substrates are useful herein. Non-limiting examples are natural mica, synthetic mica, graphite, talc, kaolin, alumina sheet, bismuth oxychloride, silica sheet, glass sheet, ceramic, titanium dioxide, CaSO, CaCO3, BaSO, borosilicate and mixtures thereof. , preferably mica, silica and alumina sheets. The surface of a substrate described above is coated with a layer of thin film or with multiple layers of thin films. The thin films are made with high refraction materials. The refractive index of these materials is generally greater than 1.8. A large variety of thin films can be used herein. Non-limiting examples are TiO2, Fe2O3, SnO2, Cr2O3, ZnO, ZnS, ZnO, SnO, Zr02, CaF2, Al203, BiOCI and mixtures thereof or in the form of separate layers, preferably Ti02, Fe203, Cr203 Sn02. In the case of multilayer structures, the thin films may be composed of materials with a high refractive index or may be composed of thin films alternated with high and low Rl materials where the high Rl film constitutes the top layer . The interference color is a function of the thickness of the thin film; The thickness for a specific color can be different between different materials. In the case of T02, a layer of 40 nm to 60 nm or a multiple of an integer of these produces a silver color, a layer of 60 nm to 80 nm produces a yellow color, a layer of 80 nm to 100 nm produces a red color, a layer of 100 nm at 130 nm produces a blue color and a layer of 130 nm at 160 nm produces a green color. In addition to the interference color, other transparent absorption pigments can be precipitated in the upper part of the Ti02 layer or simultaneously with it. Common materials are red or black iron oxide, ferric ferrocyanide, chromium oxide or carmine. It has been found that in addition to providing brightness, the color of the interference pigment significantly affects the perception of skin tone in humans. In general, the preferred colors are silver, gold, red, green and mixtures of these. Non-limiting examples of interference pigments useful herein include those supplied by Persperse, Inc. under the tradenames of PRESTIGE®, FLONAC®; those supplied by EMD Chemicals, Inc. under the tradenames TIMIRON®, COLORONA®, DICHRONA® and XIRONA®; and those supplied by Engelhard Co. under the trade names FLAMENCO®, TIMICA®, DUOCHROME®. In one embodiment of the present invention, the surface of the interference pigment is hydrophobic or hydrophobically modified. The contact angle test of the particle, as described in co-pending application serial number 60 / 469,075 filed on May 8, 2003, is used to determine the contact angle of the interference pigments. The greater the contact angle, the greater the hydrophobicity of the interference pigment. The interference pigment of the present invention has a contact angle of at least 60 °, more preferably greater than 80 °, still more preferably greater than 100 °, even more preferably greater than 100 °. The hydrophobically modified interference pigment or HMIP allows to trap the HMIP within the phases and greater deposit of the HMIP. The ratio of the HMIP to a phase varies from 1: 1 to about 1: 70, more preferably from 1: 2 to about 1: 50, more preferably from 1: 3 to about 1: 40, and with the highest preference of 1 7 to about 1: 35. In one embodiment of the present invention, HMIPs are preferably entrapped within the hydrophobic composition. This requires that the particle size of the hydrophobic composition in general be larger than the HMIP. In a preferred embodiment of the invention, the particles of the hydrophobic composition contain only a small number of HMIP per particles of the hydrophobic composition. Preferably this is less than 20, more preferably less than 10, most preferably less than 5. These parameters, the relative size of the HMIP and the approximate number of HMIP particles per particles of the hydrophobic composition can be determined using inspection visual with light microscopy. The HMIP and the hydrophobic composition can be mixed in the composition by means of a premix or separately. For the case of the separate addition, the hydrophobic pigments are divided into the hydrophobic composition during the formulation process. The HMIP of the present invention preferably has a hydrophobic coating comprising up to about 20 percent, more preferably up to about 15 percent, and even more preferably up to about 10 percent by total weight of the particle. The HMIP of the present invention preferably has a hydrophobic coating comprising at least about 0.1 percent by weight of the total weight of the particle, more preferably at least about 0.5 percent by weight, and even more preferably at least about 1 percent by weight. cent in weight. Non-limiting examples of hydrophobic surface treatments useful herein include silicones, acrylate and silicone copolymers, acrylate polymers, alkylsilane, isopropyl titanium triisostearate, sodium stearate, magnesium myristate, perfluoroalcohol phosphate, perfluoropolyimethyl isopropyl ether, lecithin, carnauba wax, polyethylene, chitosan, lauroyl lysine, vegetable lipid extracts and mixtures thereof, preferably silicones, silanes and stearates. Some manufacturers of surface treatments are US Cosmetics, KOBO Products Inc. and Cardre Inc. Non-Foaming Structured Aqueous Phase In a preferred embodiment, the multi-phase compositions of mild liquid body soap may comprise at least two visually distinct phases wherein by at least one phase comprises a non-foaming structured aqueous phase. The non-foaming structured aqueous phase of the composition comprises a water and water structuring agent. The non-foaming structured aqueous phase can be hydrophilic and in a preferred embodiment, it is a hydrophilic, gelled aqueous phase. In addition, the non-foaming structured aqueous phase typically comprises less than about 5%, preferably less than about 3%, and more preferably less than about 1%, by weight of the structured, non-foaming aqueous phase, of a surfactant. In one embodiment of the present invention, the structured non-foaming aqueous phase does not contain surfactant. The non-foaming structured aqueous phase has a preferred rheology profile as defined by the consistency value (k) and the cut-off index (n). Preferred consistency values of the nonfoaming structured aqueous phase are from about 1 to about 1000 Pa / (1 / s) (about 10 to about
100. 000 poise / (1 / s)), preferably from about 1 to about 100 Pa / (1 / s) (about 10 to about 10,000 poise / (1 / s)), and more preferably from about 10 to about 100 Pa / (1 / s) (approximately 100 to approximately 1,000 poise / (1 / s)). The cutting index of the non-foamed structured aqueous phase generally ranges from about 0.1 to about 0.8, preferably from about 0.1 to about 0.5, and more preferably from about 0.20 to about 0.4. The value of the cut index (n) and the consistency value (k) are industry standards well known and accepted to inform the viscosity profile of materials whose viscosity is a function of an applied cut index. The methodology used to obtain these values is described in greater detail in the co-pending US patent application. no. of series 60 / 542,710 filed on February 6, 2004. The structured non-foaming aqueous phase of the present invention comprises from about 30% to about 99% water, by weight. The non-foaming structured aqueous phase generally comprises more than about 50%, preferably more than about 60%, still more preferably more than about 70%, and more preferably more than about 80% water, by weight. The pH of the structured non-foaming aqueous phase generally ranges from about 5 to about 8, more preferably the pH is about 7. Optionally, the non-foaming structured aqueous phase may comprise a pH regulator to obtain the pH suitable. The non-foaming structured aqueous phase may have a net cationic charge, a net anionic charge or a neutral charge. In a preferred embodiment, the structured non-foaming aqueous phase has a net anionic charge. The non-foaming structured aqueous phase of the compositions herein may also comprise optional ingredients such as those described below. Preferred optional ingredients for the non-foaming structured aqueous phase include pigments, pH regulators, and preservatives. In one embodiment, the non-foaming structured aqueous phase comprises a water structuring agent (for example a cross-linked polymer of acrylates / vinyl isodecanoate), water, a pH regulator (for example triamtanolamine) and a preservative (for example 1, 3-dimethylol-5,5-dimethylhydantoin ("DMDMH" available from Lonza under the tradename GLYDANT®)). A) Water Structuring Agent The structured non-foaming aqueous phase comprises from about 0.1% to about 30%, preferably from about 0.5% to about 20%, more preferably from about 0.5% to about 10%, and even more so Preferably from about 0.5% to about 5%, by weight of the structured, non-foaming aqueous phase, of a water structuring agent. The water structuring agent is generally selected from the group comprising inorganic water structuring agents, water-laden polymeric agents, water-soluble polymer structuring agents, water-structuring agents, and mixtures thereof. Non-limiting examples of water structuring inorganic agents for use in the body-gentle liquid soap composition include silicas, clays such as synthetic silicates (XLG laponite and Southern Clay XLS laponite), or mixtures thereof. Non-limiting examples of water-laden polymeric agents for use in the body-gentle liquid soap composition include acrylate / vinyl isodecanoate crosslinked polymer (Stabylen 30 of 3V), C10 alkyl acrylate / acrylate crosslinked polymer -30 (Pemulen TR1 and TR2), carbomers, ammonium acryloyldimethyltaurate / VP copolymer (Aristoflex AVC from Clariant), cross-linked polymer of ammonium acryloyldimethyltaurate / methacrylate beheneth-25 copolymer (Aristoflex HMB by Clariant), acrylates / ceteth-20 Itaconate (Structure 3001 by National Starch), polyacrylamide (Sepigel 305 by SEPPIC), or mixtures thereof. Non-limiting examples of water-soluble polymeric structuring agents for use in the body-gentle liquid soap composition include cellulose gel, hydroxypropylstarch phosphate (XL structured from National Starch), polyvinyl alcohol, or mixtures thereof. Non-limiting examples of aspociative water-structuring agents for use in the body-gentle liquid soap composition include xanthan gum, gum gellum, pectin, alginate, or mixtures thereof. Ultracentrifugation method: The ultracentrifugation method is used to determine the percentage of a structured domain or an opaque structured domain that is present in a body-gentle liquid soap composition comprising a surfactant component. The method comprises separating the composition by means of ultracentrifugation in separate but distinguishable layers. The body-gentle liquid soap composition of the present invention can have multiple distinguishable layers, for example an unstructured surfactant layer, a structured surfactant layer, and a beneficial component layer. First, dispense approximately 4 grams of liquid body soap product into a Beckman centrifuge tube (11x60 mm).
Then, place the centrifuge tubes in an ultracentrifuge (Beckman Model L8-M or equivalent) and adjust the ultracentrifuge to the following conditions: 5235 rad / s (50,000 rpm), 18 hours, and 25 ° C. After centrifuging for 18 hours, determine the relative phase volume by measuring the height of each layer using an electronic digital gauge (within 0.01 mm). First, measure the height as Ha that includes all the materials in the ultracentrifuge tube. Second, measure the height of the beneficial component as Hb. Third, measure the structured surfactant layer as Hc. The beneficial component layer is determined by its low moisture content (less than 10% water as measured by Karl Fischer titration). It usually occurs at the top of the centrifuge tube. The total height of the surfactant layer (Hs) can be measured by means of this equation:
Hs = Ha - H
The components of the structured surfactant layer may comprise several layers or a single layer. After ultracentrifugation, there is generally an isotropic layer in the bottom or near the bottom of the ultracentrifuge tube. This clear isotropic layer usually represents the unstructured micellar surfactant layer. The layers above the isotropic layer generally comprise a higher concentration of surfactant with larger ordered structures (such as liquid crystals). These structured layers are often opaque to the naked eye, or translucent, or clear. There is usually a distinct phase boundary between the structured layer and the unstructured isotropic layer. The physical nature of the structured surfactant layers can be determined through light microscopy. Structured surfactant layers typically exhibit a distinctive texture under polarized light. Another method to characterize the structured surfactant layer is to use the X-ray diffraction technique. The structured surfactant layer exhibits multiple lines that are often associated mainly with the long spaces of the liquid crystal structure. Finally, the structured domain-volume relationship is calculated based on the following equation:
Structured domain relationship - volume = Hc / Hs * 100%
If there is no beneficial component layer present, use the total height as the height of the surfactant layer, Hs = Ha. Method of determining the yield point An AR2000 controlled stress rheometer from TA Instruments can be used to determine the yield point of the component. For the purposes of the present invention, the yield point of the surfactant component or the soft liquid soap composition for the body is the amount of effort required to produce the flow start, where a significant increase in the velocity of the tension occurs. The determination is made at 25 ° C with the measuring system of parallel plate 4 cm in diameter and 1 mm apart. The determination is made by means of the programmed application of a continuous increase of a cutting effort (normally from approximately 0.1 Pa to approximately 500 Pa) during a time interval of 5 minutes, collecting 30 data points per decade of effort in one effort progression evenly spaced. The stress results in a deformation of the sample, and a shear stress versus tension curve can be created. The shear stress (Pa) is plotted on a curve on the x axis versus the stress on the y axis using logarithmic scales for both axes. The composition of mild liquid soap for the body and the surfactant component that are structured exhibit an initial region at low stresses that appears as a straight line when drawn in this way. The yield point is the stress point at which the observed stress deviates by more than 10% from a regression line (ie from predicted stress) extended from the region of the initial straight line in the log-log plot , determined by the linear regression of the transformed log-log stretch-stress data between 0.2-2.0 Pa, and continues to deviate by an amount increasing and accelerating substantially with each subsequent point, so that the flow occurs. The surfactant component is measured before being combined in the composition, or after being combined in the composition by separating the compositions by suitable non-destructive physical separation means.
Density method (specific gravity) The metal pycnometer is used to determine the density (specific gravity) of both the cleansing phase and the beneficial phase compositions. A suggested type of metallic pycnometer can be obtained from Fisher, 3-347. Another equivalent pycnometer can also be used. The following procedure is the steps to measure the density (specific gravity) of the cleaning phase compositions and those of the beneficial phase. Step 1) Cleaning: The metal pycnometer should be clean and dry before use. Completely dismantle the metal pycnometer and wash all parts thoroughly with water. After rinsing with water, rinse with alcohol. Expel alcohol with a clean, dry air flow. Step 2) Standardization Fill the dry and clean pycnometer with distilled water at 25 ° C. Place the cap on the body of the pyknometer and screw the cap firmly into place. Dry the outer part of the pyknometer with a disposable tissue and weigh 0.001 g. Clean and dry the pyknometer according to the instructions above. Assemble and weigh the dry pycnometer at 0.001 g.
Water weight = Weight of the pycnometer and weight of water in the empty pycnometer- Step 3) Sample measurement Clean and dry the pyknometer according to the instructions shown above. Allow the sample to equilibrate at room temperature. Pour the sample into the pyknometer, taking care to avoid introducing air into the sample inside the pyknometer. Add an additional part of the sample so that it extends slightly above the top of the threads. Place the cap inside the cap and screw it firmly into the body of the pyknometer. Any additional amount of the sample will be forced through a hole in the cap of the pyknometer. Wipe off excess sample carefully using a disposable tissue. Weigh the filled pycnometer to 0.001 g.
Weight of the sample = Weight of the pyknometer and weight of the sample in the pyknometer.
Step 4) Specific gravity = Sample weight / Water weight The difference in density between the cleaning phase and the beneficial phase is less than 0.15 g / cm3, preferably the difference in density is less than 0.10 g / cm3, with greater preference less than 0.05g / cm3 and even more preferably less than 0.01 g / cm3. METHOD OF USE The soft body soap compositions of the present invention are preferably applied topically to the skin or hair in an amount sufficient to provide effective delivery of the skin cleansing agent, the hydrophobic component, and the particles to the applied surface. The compositions can be applied directly to the skin or indirectly using a tassel to clean, a washcloth, a sponge or other implement. Preferably, the compositions are diluted with water before, during or after topical application and subsequently rinsed or cleaned from the skin or hair, preferably rinsed with water or cleaned with a water-insoluble substrate combined with water. Therefore, the present invention is also directed to methods that cleanse the skin through the above described application of the compositions of the present invention. The methods of the present invention may also be directed to a method for providing effective delivery of the desired active agent for skin care, and to the benefits resulting from this effective delivery as described herein, to the surface applied to the skin. through the application described above of the compositions of the present invention. Manufacturing Method The soft body liquid soap composition of the present invention can be prepared by any known technique or in any other effective way, suitable for making and formulating the desired product. Non-limiting examples of such methods in that they apply to specific embodiments of the present invention are described in the following examples.
In a preferred embodiment of the present invention the multiphase composition of mild body soap liquid can be prepared by any known or otherwise effective technique to make and formulate the desired form of multiphase product. It is effective to combine the filling technology of the toothpaste tubes as a rotating stage design. In addition, the present invention can be prepared in accordance with the method and apparatus described in U.S. Pat. no. 6,213,166. The method and the apparatus are used to fill a single container with two or more compositions with a spiral configuration. The method requires at least two nozzles to fill the container. The container is placed in a static mixer and rotated until the composition is introduced into the container. Another effective way consists in combining at least two phases by first placing the separated compositions in individual storage tanks having a pump and a hose attached thereto. The phases are pumped in predetermined quantities in a single combination section. Then, the phases are moved from the combination sections to the mixing sections where the phases are mixed, so that this single resulting product shows a distinctive pattern of the phases. The pattern is selected from the group comprising striped, marbled, geometric patterns, and mixtures thereof. The next step involves pumping the product that was mixed in the mixing section by means of a hose to a single nozzle, then placing the nozzle in a container and filling it with the resulting product. Non-limiting examples of such methods in that they apply to specific embodiments of the present invention are described in the following examples. If the soft body liquid soap composition comprises multi-phase personal care compositions comprising patterns of various colors, it may be desired to package these compositions in a transparent or translucent container so that the consumer can see the pattern through the container. Due to the viscosity of the present compositions, it may also be desirable to include instructions for the consumer to store the package upside down, on its lid to facilitate shipping. It will be understood that each maximum numerical limitation given in this specification will include any lower numerical limitation, as if the lower numerical limitations had been explicitly annotated herein. All minimum numerical limits cited in this specification shall include all major numerical limits, as if such numerical major limits had been explicitly quoted herein. All numerical ranges cited in this specification shall include all minor intervals that fall within the larger numerical ranges, as if all minor numerical ranges had been explicitly quoted herein. All parts, ratios and percentages used herein, in the specification, examples and claims are expressed by weight and all numerical limitations are used at the usual level of precision allowed by the industry, unless otherwise indicated.
Examples The following examples further describe and demonstrate the embodiments within the scope of the present invention. The examples are provided for illustrative purposes only and should not be construed as limiting the present invention since many variations thereof are possible without deviating from their spirit and scope.
Examples 1 to 3 The following described examples are non-limiting examples of a body-gentle liquid soap composition.
The compositions described above can be prepared by a conventional combination and mixing techniques. Combine the following ingredients: distilled water, guar hydroxypropyltrimonium chloride, citric acid, anhydrous USP, and glycerin. Heat the mixture to 65-70 ° C while stirring the mixture. Keep stirring until a homogeneous solution is formed. Once homogenous, keep the temperature at 65-70 ° C and add the following ingredients: PEG 90M. Hampene NA2 (Dissolvine NA-2X), Trideceth sodium sulfate, sodium lauroamphoacetate, steareth-2. Then add petrolatum and mix until the mixture becomes homogeneous. Once homogenous, add sodium chloride and mix until the mixture becomes homogeneous. Adjust the pH to 5.8-6.2 using citric acid. Finally, cool the mixture to 48 ° C and add the following ingredients: perfume and DMDM hydantoin.
Examples 4-10 The following described examples are non-limiting examples of a multi-phase composition of mild body soap liquid.
The compositions described above can be prepared by a conventional combination and mixing techniques. Prepare the composition of the first phase by first adding citric acid in water in a 1: 3 ratio to form a premix of citric acid. Then, add the following ingredients in the main mix container in the following sequence: water, sodium trideceth sulfate, sodium lauroamphoacetate, steareth-2, sodium chloride, sodium benzoate, disodium EDTA, Glydant. Heat at 65-70 ° C. Begin stirring the main mixing vessel. In a separate mixing vessel, disperse the polymers (Polyquaterium 10. Jaguar C-17 or N-Hance 3196) in water in a ratio of 1: 10 and form a polymer premix. Add the fully dispersed polymer premix into the main mixing vessel with continuous agitation. Disperse the Poiyox WSR 301 in water and then add it to the main mixing vessel. Then, add the rest of the water. Chill at 48 ° C and add perfume in the batch. Hold the agitation until a homogeneous solution is formed. The second phase can be prepared by adding petrolatum in a mixing vessel. Heat the container to 88 ° C (190 ° F). Then add mineral oil and particles. Apply high cutting effort to the batch to ensure adequate particle dispersion. Continue shaking the batch and cool slowly to room temperature. These phases can be combined by placing the separated phases in separate storage tanks that have attached a pump and a hose. The phases are pumped in predetermined quantities in a single combination section. Then, the phases are moved from the combination sections to the mixing sections where the phases are mixed, so that this single resulting product shows a distinctive pattern of the phases. The pattern is selected from the group comprising striped, marbled, geometric patterns, and mixtures thereof. The next step involves pumping the product that was mixed in the mixing section by means of a hose to a single nozzle, then placing the nozzle in a container and filling it with the resulting product. The product remains stable under ambient conditions for at least 180 days.
Examples 11 to 12 The following described examples are non-limiting examples of a multi-phase composition and particulate of mild liquid body soap.
The compositions described above can be prepared by a conventional combination and mixing techniques. Prepare the composition of the first phase by first adding citric acid in water in a 1: 3 ratio to form a premix of citric acid. Then, add the following ingredients in the main mix container in the following sequence: water, sodium trideceth sulfate, sodium lauroamphoacetate, steareth-2, sodium chloride, sodium benzoate, disodium EDTA, Glydant. Heat at 65-70 ° C. Begin stirring the main mixing vessel. In a separate mixing vessel, disperse the polymers (Polyquaterium 10. Jaguar C-17 or N-Hance 3196) in water in a ratio of 1: 10 and form a polymer premix. Add the fully dispersed polymer premix into the main mixing vessel with continuous agitation. Disperse the Poiyox WSR 301 in water and then add it to the main mixing vessel. Then, add the rest of the water. Chill at 48 ° C and add perfume in the batch. Hold the agitation until a homogeneous solution is formed. The second phase can be prepared in a similar manner by conventional formulation and mixing techniques. Prepare by first adding citric acid to the water in a ratio of 1: 3 to form a premix of citric acid. After, add the following ingredients in the container of the main mixture in the following sequence: water, trideceth sodium sulfate, sodium lauroamphoacetate, laureth-2, sodium chloride, sodium benzoate, disodium EDTA, Glydant. Heat at 65-70 ° C. Begin stirring the main mixing vessel. In a separate mixing vessel, disperse the polymers (Polyquaterium 10. Jaguar C-17 or N-Hance 3196) in water in a ratio of 1: 10 and form a polymer premix. Add the fully dispersed polymer premix into the main mixing vessel with continuous agitation. Disperse the Poiyox WSR 301 in water and then add it to the main mixing vessel. Then, add the rest of the water. Chill at 48 ° C and add perfume in the batch. Finally, add the particulate material and maintain the agitation until a homogeneous solution is formed. These phases can be combined by placing the separated phases in separate storage tanks that have attached a pump and a hose. The phases are pumped in predetermined quantities in a single combination section. Then, the phases are moved from the combination sections to the mixing sections where the phases are mixed, so that this single resulting product shows a distinctive pattern of the phases. The pattern is selected from the group comprising striped, marbled, geometric patterns, and mixtures thereof. The next step involves pumping the product that was mixed in the mixing section by means of a hose to a single nozzle, then placing the nozzle in a container and filling it with the resulting product. The product remains stable under ambient conditions for at least 180 days
Examples 13 to 14 The following described examples are non-limiting examples of a multi-phase composition and particulate of mild liquid soap for the body.
The compositions described above can be prepared by a conventional combination and mixing techniques. Prepare the first phase composition by first adding the citric acid in water and adding the cationic polymer, mixing to dissolve. Add the Expancel with slight agitation only to minimize the foam. Then, add the surfactants and shake until homogeneous and free flowing. Add the sodium chloride and stir until the composition is thick and homogeneous. In a separate container, prepare a premix of xanthan gum and perfume, which will have a paste-like consistency. While stirring the composition in a mixing vessel, add the premix within one minute of completion and shake vigorously to disperse the polymer until the lumps disappear. Add all the remaining ingredients and mix until the mixture becomes homogeneous. Adjust the pH to between 6.1 - 6.5. The second phase can be prepared by adding petrolatum in a mixing vessel. Heat the container to 88 ° C (190 ° F). Then add mineral oil and particles. Apply a high cutting effort to the batch to ensure adequate particle dispersion. Continue shaking the batch and cool slowly to room temperature. These phases can be combined by placing the separated phases in separate storage tanks that have attached a pump and a hose. The phases are pumped in predetermined quantities in a single combination section. Then, the phases move from the combination sections to the mixing sections where the phases are mixed, so that this single resulting product shows a distinctive pattern of the phases. The pattern is selected from the group comprising striped, marbled, geometric patterns, and mixtures thereof. The next step involves pumping the product that was mixed in the mixing section by means of a hose to a single nozzle, then placing the nozzle in a container and filling it with the resulting product. The product remains stable under ambient conditions for at least 180 days. All documents cited in the Detailed Description of the invention are incorporated in their relevant parts as reference in the present document; The citation of any document should not be construed as an admission that it constitutes a prior industry with respect to the present invention. While particular embodiments of the present invention have been illustrated and described, it will be apparent to those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the invention. It has been intended, therefore, to cover in the appended claims all changes and modifications that are within the scope of the invention.
Claims (31)
1. A body-gentle liquid soap composition characterized by: (a) a surfactant component comprising: (i) a non-ionic surfactant having a hydrophilic-lipophilic balance of about 1.5 to 13.0; (ii) an anionic surfactant; and (b) an electrolyte; and wherein the composition comprises a structured domain.
2. The soft body liquid soap composition according to claim 1, further characterized in that it additionally comprises an amphoteric surfactant, a zwitterionic surfactant and mixtures thereof.
The soft body liquid soap composition according to claim 1 or 2, further characterized in that it comprises from about 1% to about 95%, by weight of the composition, of the surfactant component.
4. The soft body liquid soap composition according to any of the preceding claims, further characterized in that it comprises from about 5% to about 95%, by weight of the composition, of a surfactant component.
5. The soft body liquid soap composition according to any of the preceding claims, further characterized in that the anionic surfactant is selected from the group comprising alkyl ether sulphates, alkylsulfonates and mixtures thereof.
6. The body-gentle liquid soap composition according to any of the preceding claims, further characterized in that the amphoteric surfactant is selected from the group consisting of sodium lauroanfoacetate, sodium cocoamphoacetate, sodium dilauroanfoacetate, disodium cocodianfoacetate, and mixtures thereof. .
The soft body liquid soap composition according to any of the preceding claims, further characterized in that the nonionic surfactant is selected from the group comprising glyceryl monohydroxystearate, steareth-2, propylene glycol stearate, PEG-2 stearate, sorbitan monostearate, glyceryl stearate, laureth-2, and mixtures thereof.
The liquid body soap composition according to any one of the preceding claims, further characterized in that the electrolyte is selected from the group comprising sodium chloride, ammonium chloride, sodium sulfate, ammonium sulfate, and mixtures thereof. these.
9. The soft body liquid soap composition according to any of the preceding claims, further characterized in that the structured domain is an opaque structured domain.
10. The soft body liquid soap composition according to claim 9, further characterized in that the opaque structured domain is a lamellar phase.
11. The body-gentle liquid soap composition according to any of the preceding claims, further characterized in that it additionally comprises at least about 0.5%, by weight of the composition, of a fragrance.
12. The liquid body soap composition according to any of the preceding claims, further characterized in that the composition is practically free of a polysiloxane.
13. The soft body liquid soap composition according to any of the preceding claims, further characterized in that the composition is practically free of alkylamines and alkanolamide.
14. The soft body liquid soap composition according to any of the preceding claims, further characterized in that the nonionic surfactant has a hydrophilic-lipophilic balance of about 3.4 to 13.0.
15. The body-gentle liquid soap composition according to claim 14, further characterized in that the non-ionic surfactant has a hydrophilic-lipophilic balance of about 3.4 to about 9.5.
16. The liquid body soap composition according to any of the preceding claims, further characterized in that the composition further comprises a beneficial component selected from the group comprising lipids, hydrocarbons, fats, oils, hydrophobic plant extracts, fatty acids, oils essentials, silicone materials, vitamins and their derivatives; sun protection agents; conservatives; anti-acne medications; antioxidants; chelating agents; essential oils, agents of perception, and particles selected from the group comprising natural, synthetic, semi-synthetic, hybrids and combinations of these.
17. A multiphase composition of mild liquid body soap characterized by at least two visually distinct phases; where the phases form a pattern; wherein the composition comprises; to. a surfactant component comprising: (iii) at least one nonionic surfactant having a hydrophilic-lipophilic balance of about 3.4 to 13.0; (iv) at least one anionic surfactant; b. an electrolyte; and wherein the composition comprises a structured domain; and wherein the visually distinct phases are packaged in direct physical contact with each other and maintain stability.
18. The multiphase composition of soft body soap liquid according to claim 17, further characterized in that it additionally comprises an amphoteric surfactant, a zwitterionic surfactant and mixtures thereof.
19. The multi-phase composition of soft liquid body soap according to claim 17, further characterized in that the visually distinct phases are selected from the group comprising a cleansing phase, a beneficial phase, a non-foaming structured aqueous phase, and combinations thereof.
20. The multiphase composition of soft liquid soap for the body according to claim 17, further characterized in that the pattern is selected from the group- comprising striped, geometric, marbled, and combinations thereof.
21. The multiphase composition of soft liquid body soap according to claim 17, further characterized in that it additionally comprises a particle; wherein the particle is selected from the group comprising natural, synthetic, semi-synthetic, hybrid, and combinations thereof.
22. The multiphase composition of mild body soap liquid according to claim 17, further characterized in that the nonionic surfactant has a hydrophilic-lipophilic balance of about 3.4 to about 9.5.
23. The multiphase composition of soft body soap liquid according to claim 17, further characterized in that the composition further comprises an optional beneficial component selected from the group comprising vitamins and their derivatives; sun protection agents; conservatives; anti-acne medications; antioxidants; chelating agents; essential oils, agents of perception, and mixtures of these.
24. The multi-phase composition of soft liquid soap for the body according to claim 17, further characterized in that the structured domain is an opaque structured domain.
25. The multi-phase composition of soft liquid soap for the body according to claim 24, further characterized in that the opaque structured domain is a lamellar phase.
26. The multiphase composition of mild body soap liquid according to claim 17, further characterized in that the electrolyte is selected from the group comprising sodium chloride, ammonium chloride, sodium sulfate, ammonium sulfate, and mixtures thereof. .
27. The multiphase composition of mild body soap liquid according to claim 17, further characterized in that the composition is practically free of a polysiloxane.
28. The multiphase composition of soft body soap liquid according to claim 17, further characterized in that the composition is practically free of alkylamines and alkanolamide.
29. The multiphase composition of soft body soap liquid according to claim 17, further characterized in that it additionally comprises at least about 0.5%, by weight of the composition, of a fragrance.
30. A method to provide benefits for the skin or hair; the method comprises the steps of: a) dispensing an effective amount of a soft liquid body soap composition according to claim 1 onto an implement selected from the group comprising a tassel for cleaning, a wash cloth, sponge, and the human hand; b) topically applying the composition to the skin or hair using the implement; and c) removing the composition of the skin or hair by rinsing the skin or hair with water.
31. A method to provide benefits for the skin or hair; the method comprises the steps of: a) dispensing an effective amount of a multi-phase composition of mild liquid body soap according to claim 17 on an implement selected from the group comprising a tassel for cleaning, a wash cloth, sponge, and the human hand; b) apply topically the composition to the skin or hair using the implement; and c) removing the composition of the skin or hair by rinsing the skin or hair with water.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/548,740 | 2004-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA06009723A true MXPA06009723A (en) | 2007-04-20 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050192189A1 (en) | Mild body wash | |
EP1718267B1 (en) | A mild multi-phased personal care composition | |
MXPA06015097A (en) | Multi-phased personal care composition. | |
US20050276768A1 (en) | Multi-phased personal care composition | |
US20060079421A1 (en) | Stable multi-phased personal care composition | |
US20040223991A1 (en) | Multi-phase personal care composition | |
US20070155637A1 (en) | Structured multi-phased personal cleansing composition comprising branched anionic surfactants | |
US20050192188A1 (en) | Mild body wash | |
US20050100570A1 (en) | Multi-phase personal care composition | |
AU2005294149A1 (en) | Depositable solids | |
JP2008515922A (en) | Stable patterned multiphase personal care composition | |
MXPA06009723A (en) | A mild body wash | |
MXPA06009717A (en) | A mild multi-phased personal care composition | |
MXPA06009707A (en) | A mild body wash |